Literature DB >> 33486536

A call for HoLEP: en-bloc vs. two-lobe vs. three-lobe.

Frank Rücker1, Karin Lehrich2, Axel Böhme1, Mario Zacharias1, Sascha A Ahyai3, Jens Hansen1.   

Abstract

PURPOSE: Holmium Laser Enucleation of the Prostate (HoLEP) is widely accepted as standard laser enucleation technique for patients with benign prostate obstruction (BPO). Initially developed as a three-lobe enucleation technique, several modifications have been published. Comparison of the enucleation techniques is lacking. Therefor we aimed to compare outcomes of three enucleation techniques (en-bloc vs. two-lobe vs. three-lobe).
MATERIAL AND METHODS: We prospectively collected data of 600 patients treated between 01/2017 and 12/2017 with HoLEP for BPO. Patients were randomised to either enbloc, two-lobe, or three-lobe enucleation, respectively. Data collection consisted of parameters on operation time, perioperative parameters, and functional outcomes. Univariate and multivariate analyses (ANOVA-test for continuous variables; Chi2-test for categorical variables) were performed regarding differences between the three enucleation techniques.
RESULTS: Patient characteristics were not significantly different (all p > 0.05). Significant differences were observed with respect to overall operation time (en-bloc vs. two-lobe vs. three-lobe: 40.5 vs. 40.7 vs. 47.9, respectively; p < 0.001), speed (g/min.) (en-bloc vs. two-lobe vs. three-lobe, 1.82 vs. 1.76 vs. 1.67, respectively; p 0.006), and enucleation time (en-bloc vs. two-lobe vs. three-lobe: 31.7 vs. 32 vs. 37.7, respectively; p < 0.001). When solely comparing en-bloc vs. two-lobe enucleation, differences in terms of enucleation time, operation time, and speed were not significantly different (p 0.8, 0.9, and 0.2, respectively). Postoperative outcomes were not significantly different.
CONCLUSION: All three HoLEP enucleation techniques show similar postoperative outcomes. However, enbloc and two-lobe enucleation are significantly faster with respect to enucleation, overall operation time, and speed compared to the three-lobe technique.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.

Entities:  

Keywords:  BPO; En-bloc; Enucleation; HoLEP; Three-lobe; Two-lobe

Year:  2021        PMID: 33486536     DOI: 10.1007/s00345-021-03598-5

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  18 in total

1.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.

Authors:  M J Barry; F J Fowler; M P O'Leary; R C Bruskewitz; H L Holtgrewe; W K Mebust; A T Cockett
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

2.  Holmium laser enucleation of the prostate (HoLEP) combined with transurethral tissue morcellation: an update on the early clinical experience.

Authors:  P J Gilling; K Kennett; A K Das; D Thompson; M R Fraundorfer
Journal:  J Endourol       Date:  1998-10       Impact factor: 2.942

3.  HoLEP: the gold standard for the surgical management of BPH in the 21(st) Century.

Authors:  John Michalak; David Tzou; Joel Funk
Journal:  Am J Clin Exp Urol       Date:  2015-04-25

4.  Multicentre prospective evaluation of the learning curve of holmium laser enucleation of the prostate (HoLEP).

Authors:  Grégoire Robert; Jean-Nicolas Cornu; Marc Fourmarier; Christian Saussine; Aurélien Descazeaud; Abdel-Rahmène Azzouzi; Eric Vicaut; Bertrand Lukacs
Journal:  BJU Int       Date:  2015-08-22       Impact factor: 5.588

5.  Anteroposterior dissection HoLEP: a modification to prevent transient stress urinary incontinence.

Authors:  Fumiyasu Endo; Yoshiyuki Shiga; Shingo Minagawa; Toshihisa Iwabuchi; Akiko Fujisaki; Masahiro Yashi; Kazunori Hattori; Osamu Muraishi
Journal:  Urology       Date:  2010-06-25       Impact factor: 2.649

Review 6.  Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?

Authors:  Gero Kramer; Dieter Mitteregger; Michael Marberger
Journal:  Eur Urol       Date:  2006-12-11       Impact factor: 20.096

7.  High prevalence of benign prostatic hypertrophy in the community.

Authors:  W M Garraway; G N Collins; R J Lee
Journal:  Lancet       Date:  1991-08-24       Impact factor: 79.321

Review 8.  Benign prostatic hyperplasia.

Authors:  A Thorpe; D Neal
Journal:  Lancet       Date:  2003-04-19       Impact factor: 79.321

9.  Development of a Complete En-Bloc Technique with Direct Bladder Neck Incision: A Newly Modified Approach for Holmium Laser Enucleation of the Prostate.

Authors:  Toshiki Ito; Keita Tamura; Atsushi Otsuka; Hitoshi Shinbo; Sanki Takada; Yutaka Kurita; Hideaki Miyake
Journal:  J Endourol       Date:  2019-06-12       Impact factor: 2.942

10.  Holmium laser enucleation of the prostate (HoLEP): long-term results, reoperation rate, and possible impact of the learning curve.

Authors:  Ehab A Elzayat; Mostafa M Elhilali
Journal:  Eur Urol       Date:  2007-05-04       Impact factor: 20.096

View more
  8 in total

1.  A call for HoLEP: AEEP for mega-prostates (≥ 200 cc).

Authors:  Nicholas E Boxall; Fanourios Georgiades; Saiful Miah; Laurian Dragos; James Armitage; Tevita F Aho
Journal:  World J Urol       Date:  2021-05-12       Impact factor: 4.226

2.  Incidence and risk factors for postoperative urinary incontinence after various prostate enucleation procedures: systemic review and meta-analysis of PubMed literature from 2000 to 2021.

Authors:  Mohammad Hout; Aaron Gurayah; Maria Camila Suarez Arbelaez; Ruben Blachman-Braun; Khushi Shah; Thomas R W Herrmann; Hemendra N Shah
Journal:  World J Urol       Date:  2022-10-04       Impact factor: 3.661

3.  Randomized prospective trial of the severity of irritative symptoms after HoLEP vs ThuFLEP.

Authors:  Dmitry Enikeev; Mark Taratkin; Diana Babaevskaya; Andrey Morozov; Vladislav Petov; Roman Sukhanov; Evgeny Shpot; Vincent Misrai; Denis Chinenov; Mikhail Enikeev; Thomas Herrmann
Journal:  World J Urol       Date:  2022-06-12       Impact factor: 3.661

4.  Does prior transurethral resection of prostate have a negative impact on the outcome of holmium laser enucleation of prostate? Results from a prospective comparative study.

Authors:  Usama Khater; Nicholas Anthony Smith; Jonathan E Katz; Abhishek Bhat; Indraneel Banerjee; Rashmi H Shah; Hemendra N Shah
Journal:  Urol Ann       Date:  2022-02-17

5.  Letter to the Editor regarding the article "The "Omega Sign": a novel HoLEP technique that improves continence outcomes after enucleation".

Authors:  Agostino Tuccio; Antonio Andrea Grosso; Fabrizio Di Maida; Andrea Mari; Andrea Minervini
Journal:  World J Urol       Date:  2021-03-20       Impact factor: 4.226

6.  Application of intra-arterial chemotherapy in high-risk non-muscle invasive bladder cancer: a systematic review and meta-analysis.

Authors:  Chengyu You; Xianhui Li; Yuelin Du; Hui Wang; Xiaojun Zhang; Tangqiang Wei; Anguo Wang
Journal:  PeerJ       Date:  2021-09-28       Impact factor: 2.984

7.  Outcomes of Top-Down Holmium Laser Enucleation of Prostate for Recurrent/Residual Benign Prostatic Hyperplasia: One-Year Follow-Up.

Authors:  Ahmed S Zakaria; Amr Hodhod; Loay Abbas; Moustafa Fathy; Ruba Abdul Hadi; Waleed Shabana; Anastasia Alexandra MacDonald; Ahmed Gamaleldin; Mohamed Abdallah; Mohamed Elgharbawy; Abdulrahman Ahmad; Adam Roos; Ahmed Kotb; Walid Shahrour; Hazem Elmansy
Journal:  Adv Urol       Date:  2022-09-20

8.  TURPxit or not: contemporary management options for benign prostatic obstruction.

Authors:  Thomas R W Herrmann; Vincent Misrai; Fernando Gómez Sancha; Thorsten Bach
Journal:  World J Urol       Date:  2021-07       Impact factor: 4.226

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.